Therefore, the results confirmed that the higher EFI3B mutation leads to a poor prognosis of breast cancer, and the mutation-related genes were associated with important physiological processes, which may explain the reason why the increased EIF3B leads to tumorigenesis. Here, EIF3B is linked to breast carcinoma.